Literature DB >> 12556117

Brief virtual reality therapy for public speaking anxiety.

Sandra R Harris1, Robert L Kemmerling, Max M North.   

Abstract

The primary goal of this research program was to investigate the effectiveness of virtual reality therapy (VRT) in reducing public speaking anxiety of university students. The prevalence and impact of public speaking anxiety as a type of Social Phobia are discussed. Studies of VRT as an emerging treatment for psychological problems are reviewed. In the present study, eight students completed VRT individual treatment and post-testing, and six students in a Wait-List control group completed post-testing. Assessment measures included four self-report inventories, self-report of Subjective Units of Discomfort during exposure to VRT and physiological measurements of heart rate during speaking tasks. Four weekly individual exposure treatment sessions of approximately 15 min each were conducted by the author serving as therapist. Results on self-report and physiological measures appear to indicate that four virtual reality treatment sessions were effective in reducing public speaking anxiety in university students, corroborating earlier studies of VRT's effectiveness as a psychotherapeutic modality. Future research directions are discussed, primarily the need for research on younger populations, to assess the effectiveness of VRT for earlier intervention with public speaking anxiety.

Entities:  

Mesh:

Year:  2002        PMID: 12556117     DOI: 10.1089/109493102321018187

Source DB:  PubMed          Journal:  Cyberpsychol Behav        ISSN: 1094-9313


  26 in total

Review 1.  Virtual reality exposure therapy for post-traumatic stress disorder and other anxiety disorders.

Authors:  Maryrose Gerardi; Judith Cukor; Joann Difede; Albert Rizzo; Barbara Olasov Rothbaum
Journal:  Curr Psychiatry Rep       Date:  2010-08       Impact factor: 5.285

2.  Does engagement with exposure yield better outcomes? Components of presence as a predictor of treatment response for virtual reality exposure therapy for social phobia.

Authors:  Matthew Price; Natasha Mehta; Erin B Tone; Page L Anderson
Journal:  J Anxiety Disord       Date:  2011-03-15

Review 3.  The Use of Virtual Reality Technology in the Treatment of Anxiety and Other Psychiatric Disorders.

Authors:  Jessica L Maples-Keller; Brian E Bunnell; Sae-Jin Kim; Barbara O Rothbaum
Journal:  Harv Rev Psychiatry       Date:  2017 May/Jun       Impact factor: 3.732

4.  Pilot randomized trial of self-guided virtual reality exposure therapy for social anxiety disorder.

Authors:  Nur Hani Zainal; William W Chan; Alisha P Saxena; Craig Barr Taylor; Michelle G Newman
Journal:  Behav Res Ther       Date:  2021-10-06

5.  The feasibility and acceptability of virtual environments in the treatment of childhood social anxiety disorder.

Authors:  Nina Wong Sarver; Deborah C Beidel; Josh S Spitalnick
Journal:  J Clin Child Adolesc Psychol       Date:  2013-10-21

6.  Virtual reality for obsessive-compulsive disorder: past and the future.

Authors:  Kwanguk Kim; Chan-Hyung Kim; So-Yeon Kim; Daeyoung Roh; Sun I Kim
Journal:  Psychiatry Investig       Date:  2009-07-08       Impact factor: 2.505

Review 7.  Virtual reality in mental health : a review of the literature.

Authors:  Lynsey Gregg; Nicholas Tarrier
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-03-12       Impact factor: 4.519

8.  Socially anxious and confident men interact with a forward virtual woman: an experimental study.

Authors:  Xueni Pan; Marco Gillies; Chris Barker; David M Clark; Mel Slater
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

Review 9.  Studying social interactions through immersive virtual environment technology: virtues, pitfalls, and future challenges.

Authors:  Dario Bombari; Marianne Schmid Mast; Elena Canadas; Manuel Bachmann
Journal:  Front Psychol       Date:  2015-06-24

Review 10.  Studying and treating schizophrenia using virtual reality: a new paradigm.

Authors:  Daniel Freeman
Journal:  Schizophr Bull       Date:  2008-03-28       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.